More on KZR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+45.0% Growth)
- Ratings (1.7 Score)

Upcoming Events

- Earnings (3/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kezar Life Sciences (NQ:KZR)
Delayed: 6.94 +0.11 (1.61%)
Prev. Close $6.83  
Open$6.70 
52 Wk High$ 
52 Wk Low$ 
Day High$7.02 
Day Low$6.63 
P/E N/A  
EPS$ 
Volume26,422 


Feb 13, 2026 05:01 PM Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: Stonepine Capital Management, LLC
Feb 9, 2026 02:39 PM Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: BML Investment Partners, L.P.
Jan 9, 2026 06:01 AM Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
Nov 14, 2025 01:33 PM Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: Avidity Partners Management LP
Nov 13, 2025 06:24 AM Kezar Life Sciences (KZR) Misses Q3 EPS by 153c
Nov 12, 2025 04:22 PM Form 10-Q Kezar Life Sciences, For: Sep 30
Nov 12, 2025 04:08 PM Form 8-K Kezar Life Sciences, For: Nov 12
Nov 12, 2025 04:01 PM Kezar Life Sciences Reports Third Quarter 2025 Financial Results
Nov 7, 2025 04:21 PM Form 8-K Kezar Life Sciences, For: Nov 06
Nov 7, 2025 07:03 AM Kezar Life Sciences presents trial data at medical conferences
View All Articles

Entities mentioned with KZR

View All Entities